Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels in male patients with acute exacerbation of schizophrenia

被引：0
|
作者：
Genc, A. [1 ]
Kalelioglu, T. [2 ]
Karamustafalioglu, N. [2 ]
Tasdemir, A. [3 ]
Genc, E. Sena [2 ]
Akkus, M. [2 ]
Emul, M. H. [4 ]
机构：
[1] Sisli Etfal Educ & Res Hosp, Psychiat, Istanbul, Turkey
[2] Bakirkoy Res & Training State Hosp, Psychiat, Istanbul, Turkey
[3] Samsun Mental & Neurol Hlth Hosp, Psychiat, Samsun, Turkey
[4] Istanbul Univ, Psychiat, Cerrahpasa Med Sch, Istanbul, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.1.f.013
引用
收藏
页码：S232 / S233
页数：2
相关论文
共 50 条
  • [21] Urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) serum level in patients with malignant lymphomas
    Hus, I
    Cioch, M
    Jawniak, D
    Manko, J
    Dmoszynska, A
    Chrapko, M
    Hus, M
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2002, : 141 - 144
  • [22] Circulating Levels of Urokinase-Type Plasminogen Activator (uPA) and its Soluble Receptor (suPAR) in Patients with Atopic Eczema/Dermatitis Syndrome
    Alicja Kasperska-Zajac
    Barbara Rogala
    Inflammation, 2005, 29 : 90 - 93
  • [23] Circulating levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (suPAR) in patients with atopic eczema/dermatitis syndrome
    Kasperska-Zajac, Alicja
    Rogala, Barbara
    INFLAMMATION, 2005, 29 (2-3) : 90 - 93
  • [24] Release of the Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) by Activated Neutrophils in Rheumatoid Arthritis
    Boris K. Pliyev
    Mikhail Yu. Menshikov
    Inflammation, 2010, 33 : 1 - 9
  • [25] Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) As a Biomarker of Renal Outcomes in AL Amyloidosis
    Kastritis, Efstathios
    Papassotiriou, Ioannis
    Theodorakakou, Foteini
    Margeli, Alexandra
    Barzteliotou, Anastasia
    Tsiligkeridou, Eleni
    Andreatou, Amalia
    Fotiou, Despina
    Migkou, Magdalini
    Kanellias, Nikolaos
    Dialoupi, Ioanna
    Ntanasis-Stathopoulos, Ioannis
    Malandrakis, Panagiotis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD, 2020, 136
  • [26] Soluble urokinase-type plasminogen activator receptor, suPAR, as a prognostic biomarker in advanced pancreatic cancer
    Eefsen, Rikke Lovendahl
    Christensen, Ib Jarle
    Calatyud, Dan
    Johansen, Astrid Zedlitz
    Chen, Inna Markovna
    Rasmussen, Louise Skau
    Pfeiffer, Per
    Hollander, Niels Henrik
    Andersen, Fahimeh
    Johansen, Julia S.
    Hoyer-Hansen, Gunilla
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Release of the Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) by Activated Neutrophils in Rheumatoid Arthritis
    Pliyev, Boris K.
    Menshikov, Mikhail Yu.
    INFLAMMATION, 2010, 33 (01) : 1 - 9
  • [28] The levels of soluble urokinase plasminogen activator receptor (suPAR) in saliva are influenced by acute stress
    Fernandez-Botran, Rafael
    Szabo, Yvette Z.
    Lyle, Keith B.
    Newton, Tamara L.
    BIOLOGICAL PSYCHOLOGY, 2021, 165
  • [29] SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) LEVELS IN PREGNANCY AND PREECLAMPSIA
    Beko, G.
    Biro, E.
    Toldi, G.
    Stenczer, B.
    Molvarec, A.
    Rigo, J.
    Vasarhelyi, B.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S693 - S693
  • [30] Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism
    Oblitas, Crhistian-Mario
    Lopez-Rubio, Marina
    Lago-Rodriguez, Marta-Olimpia
    Galeano-Valle, Francisco
    Garcia-Gamiz, Mercedes
    Zamora-Trillo, Angielys
    Walther, Luis-Antonio Alvarez-Sala
    Demelo-Rodriguez, Pablo
    MEDICINA CLINICA, 2024, 163 (06): : 281 - 285
12345